In Madagascar, the pregnant women living with hiv antiretroviral therapy coverage for pmtct stands at 12% currently, a decrease of 1% (-7.7%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Madagascar
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Madagascar
Male unintentional poisoning
1.5
-0.2
(2021)
Female wasting in children
6.4%
+1.1%
(2021)
Female prevalence of HIV
0.2%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar18
-intl dollar0
(2022)
Birth registration
73.8%
-4.8%
(2021)
Contraceptive modern method prevalence
42.7%
+2.3%
(2021)
Madagascar PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 12% | -1% |
| 2021 | 13% | +4% |
| 2020 | 9% | -4% |
| 2019 | 13% | +2% |
| 2018 | 11% | +6% |
| 2017 | 5% | +4% |
| 2016 | 1% | -2% |
| 2015 | 3% | -1% |
| 2014 | 4% | 0% |
| 2013 | 4% | -2% |
| 2012 | 6% | -3% |
| 2011 | 9% | +7% |
| 2010 | 2% | 0% |
| 2009 | 2% | 0% |
| 2008 | 2% | -2% |
| 2007 | 4% | +1% |
| 2006 | 3% | +2% |
| 2005 | 1% | 0% |
| 2004 | 1% | +1% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |